498 related articles for article (PubMed ID: 28074285)
1. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
Schrama D; Ritter C; Becker JC
Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
[TBL] [Abstract][Full Text] [Related]
2. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
Ye B; Smerin D; Gao Q; Kang C; Xiong X
Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
[TBL] [Abstract][Full Text] [Related]
3. Analysis of TCR β CDR3 sequencing data for tracking anti-tumor immunity.
Zhang J; Ji Z; Smith KN
Methods Enzymol; 2019; 629():443-464. PubMed ID: 31727253
[TBL] [Abstract][Full Text] [Related]
4. TCR diversity - a universal cancer immunotherapy biomarker?
McNeel DG
J Immunother Cancer; 2016; 4():69. PubMed ID: 27879971
[TBL] [Abstract][Full Text] [Related]
5. TCR repertoires of intratumoral T-cell subsets.
Linnemann C; Mezzadra R; Schumacher TN
Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
[TBL] [Abstract][Full Text] [Related]
6. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
Zhang C; Huang H; Miao Y; Xiong H; Lu Z
J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
[TBL] [Abstract][Full Text] [Related]
7. High-throughput discovery of cancer-targeting TCRs.
Bunse L; Green EW; Platten M
Methods Enzymol; 2019; 629():401-417. PubMed ID: 31727251
[TBL] [Abstract][Full Text] [Related]
8. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
Han Y; Li H; Guan Y; Huang J
Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
[TBL] [Abstract][Full Text] [Related]
9. The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes.
de Greef PC; Oakes T; Gerritsen B; Ismail M; Heather JM; Hermsen R; Chain B; de Boer RJ
Elife; 2020 Mar; 9():. PubMed ID: 32187010
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.
Li N; Yuan J; Tian W; Meng L; Liu Y
Cancer Commun (Lond); 2020 Oct; 40(10):473-483. PubMed ID: 32677768
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
Front Immunol; 2020; 11():587014. PubMed ID: 33163002
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
[TBL] [Abstract][Full Text] [Related]
13. Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases.
Pandolfi F; Cianci R; Casciano F; Pagliari D; De Pasquale T; Landolfi R; Di Sante G; Kurnick JT; Ria F
J Biol Regul Homeost Agents; 2011; 25(2):153-61. PubMed ID: 21880203
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
Frank ML; Lu K; Erdogan C; Han Y; Hu J; Wang T; Heymach JV; Zhang J; Reuben A
Clin Cancer Res; 2023 Mar; 29(6):994-1008. PubMed ID: 36413126
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of the T cell receptor repertoire.
Uddin I; Woolston A; Peacock T; Joshi K; Ismail M; Ronel T; Husovsky C; Chain B
Methods Enzymol; 2019; 629():465-492. PubMed ID: 31727254
[TBL] [Abstract][Full Text] [Related]
16. Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.
Udyavar A; Geiger TL
Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):335-46. PubMed ID: 20680493
[TBL] [Abstract][Full Text] [Related]
17. TCR repertoire evolution during maintenance of CMV-specific T-cell populations.
Schober K; Buchholz VR; Busch DH
Immunol Rev; 2018 May; 283(1):113-128. PubMed ID: 29664573
[TBL] [Abstract][Full Text] [Related]
18. T-cell repertoire diversity: friend or foe for protective antitumor response?
Porciello N; Franzese O; D'Ambrosio L; Palermo B; Nisticò P
J Exp Clin Cancer Res; 2022 Dec; 41(1):356. PubMed ID: 36550555
[TBL] [Abstract][Full Text] [Related]
19. Strategies to genetically engineer T cells for cancer immunotherapy.
Spear TT; Nagato K; Nishimura MI
Cancer Immunol Immunother; 2016 Jun; 65(6):631-49. PubMed ID: 27138532
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
